0
Articles |

Pulmonary Delivery of Beclomethasone Liposome Aerosol in Volunteers : Tolerance and Safety

J. Clifford Waldrep; Caroline M. Knight; Melanie B. Black; Brian E. Gilbert; Vernon Knight; William Eschenbacher; Peter W. Scherer
Author and Funding Information

Affiliations: From the Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston,  From the Department of Microbiology and Immunology, Baylor College of Medicine, Houston,  From the Department of Medicine, Pulmonary Division, Baylor College of Medicine, Houston,  From the Department of Bioengineering, University of Pennsylvania, Philadelphia

Affiliations: From the Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston,  From the Department of Microbiology and Immunology, Baylor College of Medicine, Houston,  From the Department of Medicine, Pulmonary Division, Baylor College of Medicine, Houston,  From the Department of Bioengineering, University of Pennsylvania, Philadelphia

Affiliations: From the Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston,  From the Department of Microbiology and Immunology, Baylor College of Medicine, Houston,  From the Department of Medicine, Pulmonary Division, Baylor College of Medicine, Houston,  From the Department of Bioengineering, University of Pennsylvania, Philadelphia

Affiliations: From the Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston,  From the Department of Microbiology and Immunology, Baylor College of Medicine, Houston,  From the Department of Medicine, Pulmonary Division, Baylor College of Medicine, Houston,  From the Department of Bioengineering, University of Pennsylvania, Philadelphia


1997 by the American College of Chest Physicians


Chest. 1997;111(2):316-323. doi:10.1378/chest.111.2.316
Text Size: A A A
Published online

Abstract

Study objective: To test the tolerance and safety of single doses of beclomethasone dipropionate (Bec)-dilauroylphosphatidylcholine (DLPC) liposome aerosol in volunteers.

Design: Single-dose inhalations of liposome preparations of Bec-DLPC and DLPC alone were administered for 15 min from a jet nebulizer (Puritan-Bennett, modified twin jet; mass median aerodynamic diameter of 1.6 µm) under close clinical and laboratory surveillance. Two dose levels (0.5 mg Bec/12.5 mg DLPC per milliliter, and 1.0 mg Bec and 25 mg DLPC per milliliter in the reservoirs, respectively) were administered. The Bec doses were selected to approximate the dosages of this glucocorticoid used with metered-dose inhalers (MDIs). First, four volunteers were exposed to an initial low dose; the mean (±SD) inhaled doses were 0.56±0.07 mg of Bec and/or 14.0±1.8 mg of DLPC. Subsequently, a second group of six volunteers was exposed to a higher dose; the mean (±SD) inhaled doses were 1.29±0.14 mg of Bec and/or 34.6±6.8 mg of DLPC.

Setting: Outpatient and inpatient.

Patients: Normal male (n=6) and female (n=4) adult volunteers.

Interventions: Inhalation of Bec-DLPC and DLPC liposome aerosols in a single-dose tolerance study involving 10 normal volunteers.

Measurements and results: Spirometry, clinical observations, clinical chemistry, and hematology were monitored. No adverse clinical or laboratory events were observed.

Conclusions: Bec-DLPC liposome aqueous aerosol was well tolerated in doses equivalent to those currently administered by MDIs and dry powder inhalers for treatment of asthma.


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
Efficacy and Safety of Beclomethasone Dipropionate Extrafine Aerosol in Childhood Asthma*: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543